The California biotech firm said in a statement that it is hoping to find a buyer to address its ongoing financial struggles.| NPR
Amid its plummeting stock value, layoffs and cuts to its drug R&D program, the battered company is carrying on.| PharmaVoice
Information belonging to as many as seven million 23andMe customers has been put up for sale on criminal forums following a credential stuffing attack.| Malwarebytes